Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SABS | NAGE | CLLS | ||
| Company | Sab Biotherapeutics Inc | Niagen Bioscience Inc | Cellectis S.A. ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.51 | 3.33 | 2.73 | ||
| High | 3.78 | 3.45 | 2.80 | ||
| Low | 3.51 | 3.33 | 2.66 | ||
| Latest | 3.70 | 3.41 | 2.66 | ||
| Change | +0.19 | +0.04 | +0.06 | ||
| % Change | +5.41% | +1.19% | +2.31% | ||
| Volume | 659,079 | 123,130 | 2,213 | ||
| 20-Day Average Volume | 749,593 | 744,934 | 20,139 | ||
| Previous Close | 3.51 | 3.37 | 2.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.79 | 3.39 | 2.93 | ||
| 20-Day Raw Stochastic | 44.17% | 51.61% | 18.75% | ||
| 20-Day Relative Strength | 50.23 | 46.47 | 40.75 | ||
| Weighted Alpha | +35.41 | -60.07 | -16.20 | ||
| Today's Opinion | Hold | 88% Sell | 100% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.75% since 07/14/26 | +3.80% since 07/14/26 | -4.70% since 07/14/26 | ||
| Low | 3.47 on 07/20/26 | 3.26 on 07/20/26 | 2.59 on 07/20/26 | ||
| High | 3.78 on 07/21/26 | 3.53 on 07/16/26 | 2.87 on 07/15/26 | ||
| 1-Month | |||||
| %Chg | -6.63% since 06/18/26 | -2.43% since 06/18/26 | -8.05% since 06/18/26 | ||
| Low | 3.47 on 07/20/26 | 3.17 on 06/30/26 | 2.59 on 07/20/26 | ||
| High | 4.09 on 06/22/26 | 3.64 on 07/07/26 | 3.39 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | -1.97% since 04/21/26 | -27.95% since 04/21/26 | -31.50% since 04/21/26 | ||
| Low | 3.28 on 06/05/26 | 3.17 on 06/30/26 | 2.59 on 07/20/26 | ||
| High | 4.59 on 05/08/26 | 5.12 on 05/04/26 | 4.19 on 05/14/26 | ||
| 6-Month | |||||
| %Chg | -7.32% since 01/21/26 | -44.92% since 01/21/26 | -33.33% since 01/21/26 | ||
| Low | 3.28 on 06/05/26 | 3.17 on 06/30/26 | 2.59 on 07/20/26 | ||
| High | 5.15 on 03/12/26 | 6.41 on 01/22/26 | 4.55 on 04/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 268,389 | 268,400 | 260,881 | ||
| Shares Outstanding, K | 76,464 | 79,644 | 100,339 | ||
| Annual Sales | 0 | 129,420,000 | 79,590,000 | ||
| Annual Net Income | 13,270,000 | 17,380,000 | -67,590,000 | ||
| Last Quarter Sales | 0 | 31,470,000 | 7,550,000 | ||
| Last Quarter Net Income | -18,870,000 | 6,320,000 | -17,770,000 | ||
| 60-Month Beta | 0.52 | 2.09 | 2.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 05/12/26 | 0.07 on 05/06/26 | -0.18 on 05/11/26 | ||
| Earnings Date | 08/06/26 | 08/05/26 | 08/03/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.26 | 0.00 | ||